Cargando…
401. Risk of Post-COVID Conditions Correlates with IL-6 Plasma Levels and Is Reduced by Early Antibody Therapy
BACKGROUND: Post-COVID conditions (PCC) are common, and risk factors include older age and female sex. While high interleukin (IL)-6 and C-reactive protein are associated with more severe disease, it is unclear whether other cytokines are associated with PCC. This study was performed to identify fac...
Autores principales: | Fukuta, Yuriko, Gebo, Kelly, Heath, Sonya L, Zhu, Xianming, Baksh, Sheriza, Abraham, Alison G, Habtehyimer, Feben, Shade, David, Ruff, Jessica E, Ram, Malathi, Laeyendecker, Oliver, Fernandez, Reinaldo, Patel, Eshan U, Baker, Owen R, Shoham, Shmuel, Cachay, Edward R, Currier, Judith S, Gerber, Jonathan, Meisenberg, Barry, Hammitt, Laura, Forthal, Donald, Huaman, Moises A, Levine, Adam C, Mosnaim, Giselle, Patel, Bela, Paxton, James, Raval, Jay S, Sutcliffe, Catherine, Anjan, Shweta, Gniadek, Thomas, Kassaye, Seble, Blair, Janis E, Lane, Karen, McBee, Nichol, Gawad, Amy, Das, Piyali, Klein, Sabra L, Pekosz, Andrew, Bloch, Evan, Hanley, Daniel, Casadevall, Arturo, Tobian, Aaron, Sullivan, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677236/ http://dx.doi.org/10.1093/ofid/ofad500.471 |
Ejemplares similares
-
Early Treatment, Inflammation and Post-COVID Conditions
por: Gebo, Kelly A., et al.
Publicado: (2023) -
Early antibody treatment, inflammation, and risk of post-COVID conditions
por: Gebo, Kelly A., et al.
Publicado: (2023) -
Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study
por: Zhu, Xianming, et al.
Publicado: (2023) -
Symptom Duration and Resolution With Early Outpatient Treatment of Convalescent Plasma for Coronavirus Disease 2019: A Randomized Trial
por: Baksh, Sheriza N, et al.
Publicado: (2023) -
Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection
por: Shoham, Shmuel, et al.
Publicado: (2021)